Literature DB >> 22024860

Bilateral central serous chorioretinopathy caused by intranasal corticosteroids: a case report and review of the literature.

Andrew J Kleinberger1, Chirag Patel, Ronni M Lieberman, Benjamin D Malkin.   

Abstract

The relationship between systemic corticosteroids and central serous chorioretinopathy (CSCR) has been well established; however, there also appears to be an association with intranasal corticosteroids. A search of the English literature revealed only three reported cases of CSCR linked to intranasal corticosteroid use, and in each, clinical improvement was observed after cessation of the steroid agent. We present an additional case of bilateral CSCR resulting from intranasal corticosteroid use and review the literature regarding this uncommon side effect. Otolaryngologists, as frequent prescribers of these medications, should be aware of their myriad side effects, including ophthalmologic conditions such as CSCR.
Copyright © 2011 The American Laryngological, Rhinological, and Otological Society, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 22024860     DOI: 10.1002/lary.21967

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  7 in total

1.  Long-Term Outcome of Half-Dose Verteporfin Photodynamic Therapy for the Treatment of Central Serous Chorioretinopathy (An American Ophthalmological Society Thesis).

Authors:  Timothy Y Y Lai; Raymond L M Wong; Wai-Man Chan
Journal:  Trans Am Ophthalmol Soc       Date:  2015

2.  [Bilateral retinal detachment].

Authors:  C Melzer; F G Holz; S Schmitz-Valckenberg
Journal:  Ophthalmologe       Date:  2017-01       Impact factor: 1.059

Review 3.  Intranasal Corticosteroids and Central Serous Chorioretinopathy: A Report and Review of the Literature.

Authors:  Austin S Nakatsuka; Hossein Nazari Khanamiri; Quy N Lam; Jaafar El-Annan
Journal:  Hawaii J Med Public Health       Date:  2019-05

Review 4.  Ocular complications associated with systemic medications used in allergy/immunology practice.

Authors:  Avinash Gurbaxani; Clare L Fraser; Simon E Skalicky; Peter McCluskey
Journal:  Curr Allergy Asthma Rep       Date:  2013-06       Impact factor: 4.806

5.  Recurrent Central Serous Chorioretinopathy with Dexamethasone Eye Drop used Nasally for Rhinitis.

Authors:  Gunjan Prakash; Jain Shephali; Nath Tirupati; Pandey D Ji
Journal:  Middle East Afr J Ophthalmol       Date:  2013 Oct-Dec

6.  Temporal Association between Topical Ophthalmic Corticosteroid and the Risk of Central Serous Chorioretinopathy.

Authors:  Yuh-Shin Chang; Shih-Feng Weng; Jhi-Joung Wang; Ren-Long Jan
Journal:  Int J Environ Res Public Health       Date:  2020-12-17       Impact factor: 3.390

7.  Comparison of In Vivo Gene Expression Profiling of RPE/Choroid following Intravitreal Injection of Dexamethasone and Triamcinolone Acetonide.

Authors:  Zeljka Smit-McBride; Elad Moisseiev; Sara P Modjtahedi; David G Telander; Leonard M Hjelmeland; Lawrence S Morse
Journal:  J Ophthalmol       Date:  2016-06-27       Impact factor: 1.909

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.